COVID-19 Research
COVID-19 presents numerous ongoing challenges. Research continues into vaccines and antivirals, as well as the known and unknown effects of long covid on individual health and society more broadly. There have also been challenges with access and reimbursement in low and middle-income countries.
Employer Costs from Respiratory Infections
16 December 2024
Our latest research shows respiratory infections cost UK businesses £44 billion a year. Workplace vaccination programs and health-focused policies could help boost productivity, reduce costs, and address health inequities.
The Value of Vaccines and Taskforces
25 January 2023
Drawing on global experience, our panel will deep-dive into the effectiveness & value of vaccines and the taskforce model.
Vaccines, Antivirals, Lockdowns and COVID: Lessons from the Pandemic
18 January 2023
This webinar brings together a collection of some of the leading decision-makers and eminent policymakers from the UK Government’s COVID-19 pandemic response through the world-leading vaccination programme and extensive antiviral rollout.
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
1 July 2021
The Value in Health May issue includes the paper “How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?”. Finalised in December 2020, it includes:…
Would Waiving COVID-19 Vaccines Patents Save Lives?
18 May 2021
This blog discusses the rationale behind a COVID-19 patent waiver decision and contributes to the current debate by producing a balanced view on the benefits and…
Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic
21 April 2021
In this blog, we reflect on some of the key learnings from the recent pull and push strategies to develop COVID-19 vaccines in the UK, the…
Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making
1 September 2021
By placing a strain on health care systems and the global economy, the COVID-19 pandemic clearly shows the need to more comprehensively understand both supply- and…
Key Factors on How to Procure, Pay, Distribute and Use Vaccines for COVID-19: A European Perspective
1 May 2021
After the shock caused by the first wave of COVID-19, discovering vaccines against the virus and administering them quickly to the population became the utmost priority…
Realising The Broader Value of Vaccines in the UK: Ready for Prime Time?
1 February 2021
The COVID-19 pandemic has revealed the broad and devastating health, economic and societal impact of a highly infectious and deadly disease. In addition to the human…